Neonatal TB Vaccine Response
Author Information
Author(s): Kamath Arun T., Rochat Anne-Françoise, Valenti Mario P., Agger Else Marie, Lingnau Karen, Andersen Peter, Lambert Paul-Henri, Siegrist Claire-Anne
Primary Institution: University of Geneva
Hypothesis
Can a novel TB vaccine induce adult-like immune responses in neonates?
Conclusion
The IC31®-adjuvanted Ag85B-ESAT-6 vaccine elicited strong, adult-like immune responses in neonates.
Supporting Evidence
- IC31® induced strong Th1 and Th17 responses in both neonates and adults.
- Neonatal immunization with IC31®-adjuvanted Ag85B-ESAT-6 resulted in reduced bacterial growth after infection.
- Adult-like T cell responses were observed after a single immunization in neonates.
Takeaway
Researchers tested a new vaccine for babies against tuberculosis and found it worked just as well as in adults.
Methodology
Mice were immunized with Ag85B-ESAT-6 formulated with either IC31® or Alum, and immune responses were assessed.
Limitations
The study was conducted in mice, which may not fully predict human responses.
Participant Demographics
C57BL/6 mice, both neonates (1 week old) and adults (8-12 weeks old).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website